PETS | Blue Horseshoe Stocks

Blue Horseshoe Stocks: Options Review

Options Recap

We wrapped up last week on Friday morning’s report with a pair of fresh options ideas. We are happy to start off this new trading week with a review of the solid performances of those plays, and the subsequent gain opportunities they provided for us.

Paypal, Inc. PYPL – Paypal stock saw early gains thanks to solid numbers from its Venmo quick pay platform contained in its quarterly report. It caused us to signal interest in the PYPL Weekly $81-83 Calls and sure enough, we saw some nice chances for single-session profits.

$81 Calls – Range: 2.07-5.15 – Max Gain: 149%
$82 Calls – Range: 1.23-4.30 – Max Gain: 250%
$82.50 Calls – Range: .95-3.72 – Max Gain: 292%
$83 Calls – Range: .54-3.23 – Max Gain: 498%
____

The Procter & Gamble Co. PG- Procter and Gamble also reported on its earnings Friday morning,and recorded five year highs in sales growth. We highlighted the PG Weekly $82-84.50 Calls and swept the range with solid results there as well.

$82 Calls – Range: 2.87-5.40 – Max Gain: 88%
$82.50 Calls – Range: 2.61-5.20 – Max Gain: 99%
$83 Calls – Range: 1.70-4.70 – Max Gain: 176%
$83.50 Calls – Range: 1.80-4.14 – Max Gain: 130%
$84 Calls – Range:.96-3.49 – Max Gain: 264%
$83.50 Calls – Range: 1.05-3.15 – Max Gain: 200%
____

Fresh Options Idea:
PetMed Express, Inc. PETS 12/21 $30-35 Calls

Extended Watchlist:
YY, MYSZ, VTVT, CLDC, APHB, RMBS, APHB(Bottom play)

Blue Horseshoe Stocks: NBEV Recap & More

New Age Beverages Corp. NBEV

It was back on the 9th of this month that we selected NBEV as a potential bottom play, and wanted to kick off the week by swinging back around to recap the excellent move the stock has made for us thus far.

After seeing a low of 2.11 on the morning of our initial alert, the stock has continually risen over the eight sessions since, touching a high of 4.24 on Friday. That represents a very nice 101% move, while volume over the same period has been notably increased. We’ll continue to monitor the progress here in coming sessions.

PetMed Express Inc. PETS

Speaking of steady risers, we’ve watched PETS for quite awhile now, having mentioned it for the first time in our report from the morning of September 11th.

Subsequent to that report, we observed a low of 32.90 and despite already being a thirty dollar stock, we’ve still seen it increase gradually and significantly, culminating at Friday’s high of 53.89. That marks a 64% increase, which is absolutely fantastic for a stock in this price range.

We’ll be interested to see how the stock is affected by the company’s solid premarket earnings release today. It’s gapping up in early trading and it appears we will see our observed highs boosted yet again.

Extended Watchlist:
ATEN, ARRY, LTBR, NINE, LFIN, ACST

Blue Horseshoe Stocks: CAT Breakout & More

PetMed Express, Inc. PETS

We signaled a longer-term options idea for PETS yesterday which needs some time to ripen, but with the solid move in the stock itself, we figured we’d recap its performance since our initial alert on it six weeks ago.

We caught PETS at a low of 32.90, which makes its 43% run to 46.94 this week that much more impressive. For a thirty-dollar stock to gain more than a third of its value in a matter of just a few weeks, is no small feat.

We’ll continue to keep our selected options, the PETS 11/17 $40-50 Calls on watch over the next few weeks.

Caterpillar, Inc. CAT

Speaking of high dollar stocks that we’ve alerted and then gone on to see impressive gains, we’ve got CAT in our sights again this morning after a solid earnings beat. We’re going to want to highlight some options ideas here as well, but first, let’s talk about the incredible bullish run of Caterpillar this year.

We were talking about this stock back in March, and that same month, the stock traded for as little as 90.34, and has essentially been in a continual uptrend ever since. Measured to this morning’s new premarket high of 141.98, it represents an increase of 57% in just over six months.

As for the options we’ll want to track on the heels of CAT’s earnings beat this morning, we’ll be looking at the CAT Weekly $136-141 Calls.

Atossa Genetics, Inc. ATOS

We’d also like to quickly recap the respectable intraday performance recorded by ATOS following our alert on the stock yesterday morning.

From an early low of .50, ATOS ran to .636 for a solid 27% move which came on more than three times the monthly average volume.

On a side note, the company has also announced that it will hold a conference call tomorrow morning at 10am EDT to discuss preliminary results from the Phase I study of its proprietary oral Endoxifen, an active metabolite of the FDA-approved breast cancer drug tamoxifen. The conference call will be available through a live webcast at www.atossagenetics.com so we’ll be sure to tune in for that.

Extended Watchlist:
HMNY, RCON, ZYNE, KNL, CEMP, DXTR